Global Biometrics Clinical and Research Organization Quanticate Appoints Scott W. Clark as Head...

CAMBRIDGE, MA and LONDON--(Marketwire - October 26, 2009) - Quanticate, a global biometrics clinical research organization (CRO), today announced that it has appointed Scott W. Clark as Head of Business Development Americas for its clinical trials services and operations headquartered in Cambridge, MA. The appointment enhances the company's mission to further expand its clinical trial service capabilities with Clark managing the company's North American Business Development initiatives in support of existing and new clients. "Scott's appointment is strategically important to the continual development of our rapidly growing North American business," said Quanticate's US President Andrew MacGarvey. "Scott brings considerable success, knowledge and experience in developing new markets and operational management to our expanding... [read full story]                    

powered by